Oncology Chemotherapy Administration Safety
35 flashcards covering Oncology Chemotherapy Administration Safety for the HEALTHCARE-CE Registered Nurse CE section.
Oncology chemotherapy administration safety encompasses the protocols and practices designed to minimize risks associated with administering chemotherapy agents. The National Comprehensive Cancer Network (NCCN) provides guidelines that outline safe handling, administration, and monitoring of chemotherapy to ensure patient safety and effective treatment outcomes. Understanding these guidelines is critical for healthcare professionals involved in oncology care.
In practice exams and competency assessments, questions on this topic often focus on the correct procedures for drug preparation, administration techniques, and management of adverse effects. A common pitfall is underestimating the importance of double-checking dosages and drug interactions, which can lead to potentially harmful errors. Additionally, questions may assess knowledge of personal protective equipment (PPE) requirements and safety protocols during administration.
One concrete tip to remember is to always engage in a two-person verification process for chemotherapy orders to catch any potential discrepancies before administration.
Terms (35)
- 01
What is the recommended practice for handling chemotherapy agents to ensure safety?
Chemotherapy agents should be handled using appropriate personal protective equipment (PPE) such as gloves, gowns, and eye protection to minimize exposure risk (Joint Commission National Patient Safety Goals, current year).
- 02
How often must chemotherapy administration equipment be checked for safety?
Chemotherapy administration equipment should be inspected before each use to ensure proper function and safety (ANCC Scope and Standards of Practice).
- 03
What is the first step when preparing to administer chemotherapy?
The first step is to verify the patient's identity and the chemotherapy order, ensuring it matches the patient's records (Joint Commission National Patient Safety Goals, current year).
- 04
Under OSHA regulations, what is required when handling hazardous drugs like chemotherapy agents?
Employers must implement a written safety program that includes training, PPE, and proper disposal methods for hazardous drugs (OSHA Hazardous Drug Standards).
- 05
What should a nurse do if a patient presents with an allergic reaction during chemotherapy?
The nurse should immediately stop the infusion, assess the patient, and initiate emergency protocols as per facility guidelines (ANCC Scope and Standards of Practice).
- 06
How often should staff be trained on chemotherapy safety procedures?
Staff should receive training on chemotherapy safety procedures at least annually, or whenever there are updates to protocols (ANCC Scope and Standards of Practice).
- 07
What is required for the disposal of chemotherapy waste?
Chemotherapy waste must be disposed of in designated hazardous waste containers to prevent contamination and ensure safety (EPA guidelines).
- 08
When administering chemotherapy, what is the appropriate response to a spillage?
The area should be immediately contained, and the spill should be cleaned according to the facility’s hazardous spill protocol (Joint Commission National Patient Safety Goals, current year).
- 09
What is the recommended monitoring frequency for patients receiving chemotherapy?
Patients should be monitored for adverse effects during and after administration, typically at least every 15 minutes during the infusion (ANCC Scope and Standards of Practice).
- 10
What is the role of a double-check system in chemotherapy administration?
A double-check system involves two qualified healthcare professionals verifying the chemotherapy drug, dosage, and patient identity before administration to enhance safety (Joint Commission National Patient Safety Goals, current year).
- 11
Under which circumstances should a nurse hold chemotherapy administration?
Chemotherapy should be held if the patient exhibits signs of an active infection or significant lab abnormalities, such as low blood counts (ANCC Scope and Standards of Practice).
- 12
What is the appropriate action if a patient experiences extravasation during chemotherapy?
The infusion should be stopped immediately, and the appropriate antidote or treatment protocol should be initiated based on the specific chemotherapeutic agent involved (ANCC Scope and Standards of Practice).
- 13
What should be included in patient education regarding chemotherapy side effects?
Patients should be educated on potential side effects, such as nausea, fatigue, and signs of infection, and instructed on when to seek medical attention (Joint Commission National Patient Safety Goals, current year).
- 14
How should a nurse respond to a patient who is anxious about chemotherapy treatment?
The nurse should provide reassurance, offer information about the treatment process, and discuss coping strategies to alleviate anxiety (ANCC Scope and Standards of Practice).
- 15
What documentation is required after administering chemotherapy?
Documentation must include the drug administered, dosage, time of administration, patient response, and any adverse effects noted (ANCC Scope and Standards of Practice).
- 16
What is the recommended practice for monitoring vital signs during chemotherapy?
Vital signs should be monitored before, during, and after chemotherapy administration to detect any immediate adverse reactions (ANCC Scope and Standards of Practice).
- 17
What safety measures should be taken when administering oral chemotherapy?
Patients should be educated on proper handling, storage, and disposal of oral chemotherapy agents to prevent accidental exposure (Joint Commission National Patient Safety Goals, current year).
- 18
What is the maximum duration for which a chemotherapy infusion can be continued?
The duration of a chemotherapy infusion is determined by the specific protocol for the drug being administered, as outlined by the manufacturer (manufacturer guidelines).
- 19
What should be done if a chemotherapy drug is accidentally administered to the wrong patient?
Immediate action should be taken to assess the patient and notify the physician; follow facility protocol for medication errors (Joint Commission National Patient Safety Goals, current year).
- 20
What is the importance of using a smart pump for chemotherapy administration?
Smart pumps help prevent medication errors by providing dose error reduction software and ensuring accurate delivery of chemotherapy agents (ANCC Scope and Standards of Practice).
- 21
How often should chemotherapy protocols be reviewed and updated?
Chemotherapy protocols should be reviewed and updated at least annually or whenever new evidence or guidelines are published (ANCC Scope and Standards of Practice).
- 22
What is the recommended action if a nurse suspects a chemotherapy drug has been compromised?
The nurse should report the suspicion to the pharmacy and follow the facility's protocol for handling compromised drugs (Joint Commission National Patient Safety Goals, current year).
- 23
What is the role of the pharmacist in chemotherapy safety?
Pharmacists are responsible for verifying chemotherapy orders, preparing medications, and providing education on safe handling and administration (ANCC Scope and Standards of Practice).
- 24
How should a nurse handle a patient’s request for alternative therapies during chemotherapy?
The nurse should discuss the request with the healthcare team and provide evidence-based information on the safety and efficacy of alternative therapies (ANCC Scope and Standards of Practice).
- 25
What is the recommended procedure for verifying chemotherapy drug dosages?
Dosages should be verified against the original order and checked by a second qualified healthcare professional prior to administration (Joint Commission National Patient Safety Goals, current year).
- 26
What is the significance of patient education regarding fertility preservation before chemotherapy?
Patients should be informed about the potential impact of chemotherapy on fertility and the options available for preservation prior to treatment (ANCC Scope and Standards of Practice).
- 27
What should a nurse do if a patient refuses chemotherapy treatment?
The nurse should respect the patient's decision, provide information about the consequences, and document the refusal according to facility policy (ANCC Scope and Standards of Practice).
- 28
What is the protocol for handling a chemotherapy spill in a patient’s room?
Follow the facility's hazardous material spill protocol, which typically includes evacuating the area, using PPE, and cleaning with designated materials (Joint Commission National Patient Safety Goals, current year).
- 29
What is the importance of using a dedicated line for chemotherapy administration?
A dedicated line minimizes the risk of contamination and ensures accurate delivery of the chemotherapy agent (ANCC Scope and Standards of Practice).
- 30
What is the appropriate response if a patient experiences severe nausea after chemotherapy?
The nurse should assess the severity of nausea, administer antiemetics as ordered, and provide supportive care (ANCC Scope and Standards of Practice).
- 31
How should a nurse monitor for potential drug interactions in chemotherapy?
The nurse should review the patient's medication list and consult with a pharmacist to identify and manage potential drug interactions (ANCC Scope and Standards of Practice).
- 32
What is the recommended practice for patient follow-up after chemotherapy treatment?
Patients should have scheduled follow-up appointments to monitor for side effects and assess treatment effectiveness (ANCC Scope and Standards of Practice).
- 33
What is the significance of maintaining sterile techniques during chemotherapy preparation?
Maintaining sterile techniques prevents contamination of chemotherapy agents, ensuring patient safety (ANCC Scope and Standards of Practice).
- 34
What should be documented if a patient experiences an adverse reaction during chemotherapy?
Document the reaction, including symptoms, time of occurrence, interventions taken, and the patient's response (ANCC Scope and Standards of Practice).
- 35
What is the recommended action if a patient shows signs of infection after chemotherapy?
The nurse should notify the healthcare provider immediately and initiate the facility's protocol for managing febrile neutropenia (ANCC Scope and Standards of Practice).